The human pseudoautosomal region (PAR): Origin, function and future

被引:175
作者
Mangs, A. Helena
Morris, Brian J. [1 ]
机构
[1] Univ Sydney, Basic & Clin Genom Lab, Sch Med Sci, Sydney, NSW 2006, Australia
[2] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia
关键词
pseudoauitosomal region; PAR; sex chromosomes; XE7; SHOX;
D O I
10.2174/138920207780368141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pseudoautosomal regions (PARI and PAR2) of the human X and Y chromosomes pair and recombine during meiosis. Thus genes in this region are not inherited in a strictly sex-linked fashion. PARI is located at the terminal region of the short arms and PAR2 at the tips of the long arms of these chromosomes. To date, 24 genes have been assigned to the PAR1 region. Half of these have a known function. In contrast, so far only 4 genes have been discovered in the PAR2 region. Deletion of the PARI region results in failure of pairing and male sterility. The gene SHOX (short stature homeobox-containing) resides in PAR1. SHOX haploinsufficiency contributes to certain features in Turner syndrome as well as the characteristics of Leri-Weill dyschondrosteosis. Only two of the human PARI genes have mouse homologues. These do not, however, reside in the mouse PARI region but are autosomal. The PAR regions seem to be relics of differential additions, losses, rearrangements and degradation of the X and Y chromosome in different mammalian lineages. Marsupials have three homologues of human PAR1 genes in their autosomes, although, in contrast to mouse, do not have a PAR region at all. The disappearance of PAR from other species seems likely and this region will only be rescued by the addition of genes to both X and Y, as has occurred already in lemmings. The present review summarizes the current understanding of the evolution of PAR and provides up-to-date information about individual genes residing in this region.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 94 条
[1]   Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: Role in IL-8 release [J].
Abdelilah, SG ;
Latifa, K ;
Esra, N ;
Cameron, L ;
Bouchaib, L ;
Nicolaides, NC ;
Levitt, RC ;
Hamid, Q .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2768-2774
[2]   A role for TSLP in the development of inflammation in an asthma model [J].
Al-Shami, A ;
Spolski, R ;
Kelly, J ;
Keane-Myers, A ;
Leonard, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :829-839
[3]   SHOX mutations in dyschondrosteosis (Leri-Weill syndrome) [J].
Belin, V ;
Cusin, V ;
Viot, G ;
Girlich, D ;
Toutain, A ;
Moncla, A ;
Vekemans, M ;
Le Merrer, M ;
Munnich, A ;
Cormier-Daire, V .
NATURE GENETICS, 1998, 19 (01) :67-69
[4]   A novel class of pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis [J].
Benito-Sanz, S ;
Thomas, NS ;
Huber, C ;
del Blanco, DG ;
Aza-Carmona, M ;
Crolla, JA ;
Maloney, V ;
Argente, J ;
Campos-Barros, A ;
Cormier-Daire, V ;
Heath, KE .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (04) :533-544
[5]  
BENITOSANZ S, 2006, HUM MUTAT, V10, P1062
[6]   Cytogenetics of collared lemmings (Dicrostonyx groenlandicus) - I. Meiotic behavior and evolution of the neo-XY sex-chromosome system [J].
Berend, SA ;
Hale, DW ;
Engstrom, MD ;
Greenbaum, IF .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (3-4) :288-292
[7]   Interleukin-9 receptor expression in asthmatic airways in vivo [J].
Bhathena, PR ;
Comhair, SAA ;
Holroyd, KJ ;
Erzurum, SC .
LUNG, 2000, 178 (03) :149-160
[8]   Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone [J].
Binder, G ;
Schwarze, CP ;
Ranke, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :245-249
[9]   SHOX haploinsufficiency and Leri-Weill dyschondrosteosis:: Prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity [J].
Binder, G ;
Renz, A ;
Martinez, A ;
Keselman, A ;
Hesse, V ;
Riedl, SW ;
Häusler, G ;
Fricke-Otto, S ;
Frisch, H ;
Heinrich, JJ ;
Ranke, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4403-4408
[10]   Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial [J].
Blum, Werner F. ;
Crowe, Brenda J. ;
Quigley, Charmian A. ;
Jung, Heike ;
Cao, Dachuang ;
Ross, Judith L. ;
Braun, LeeAnn ;
Rappold, Gudrun .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) :219-228